Biopharmaceuticals Market Share, Analysis, and Growth by 2028
Biopharmaceuticals Market: Strategic Insights
Biopharmaceuticals Market
-
CAGR (2022 - 2028)13.4% -
Market Size 2022
US$ 329.97 Billion -
Market Size 2028
US$ 700.87 Billion
Market Dynamics
GROWTH DRIVERS
- Advancements in gene therapies
- Rising demand for personalized medicine
- Growth in biologic drug development
FUTURE TRENDS
- Expansion of biologics for treating rare and chronic diseases
- Growing adoption of biologic drugs in oncology and immunology
- Advancements in genetic and cell-based therapies
OPPORTUNITIES
- Rising demand for biologics in treating chronic diseases
- Expanding market for targeted therapies
- Growth in gene and cell therapies
Key Players
- Amgen Inc
- AbbVie Inc
- Eli Lilly and Co
- Bristol Myers Squibb Co
- Johnson Johnson
- Thermo Fisher Scientific Inc
- AGC Biologics AS
- Lonza Group AG
- WuXi Biologics Inc
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Product Type - Monoclonal Antibodies
- Recombinant Vaccines
- Conventional Vaccines
- Recombinant Growth Factors
- Purified Proteins
- Recombinant Proteins
- Recombinant Hormones
- Recombinant Enzymes
- Cell & Gene Therapies
- Cytokines/Interferon/Interleukins
Application - Oncology
- Inflammatory & Infectious Disease
- Autoimmune Disorders
- Metabolic Disorders
- Hormonal Disorders & Growth Failure
- Cardiovascular Diseases
- Neurological Diseases
Get Free Sample For